| Full Name | Tuan Tran |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 11 Years |
| Location | 1 Memorial Dr, Alton, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821432774 | NPI | - | NPPES |
| 036157323 | Medicaid | IL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center Grapevine | Grapevine, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathologists Bio-medical Laboratories Pllc | 7911961677 | 46 |
News Archive
Millions of individuals all over the country suffer from obesity, preventing them from living an active lifestyle, as well as causing a number of health conditions, such as heart disease, diabetes, and high blood pressure.
Five health prevention strategies could save more than 100,000 lives a year, according to recent research reported in the March issue of Mayo Clinic Women's HealthSource.
Researchers used ultrasound to measure the thickness of the inner walls of the neck (carotid) arteries that supply blood to the brain. Increasing carotid artery intima-media thickness (CIMT) indicates the fatty buildup of plaque within arteries feeding the heart muscle and the brain, which can lead to heart attack or stroke.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
› Verified 7 days ago
| Entity Name | Pathologists Bio-medical Laboratories Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265477707 PECOS PAC ID: 7911961677 Enrollment ID: O20041112001162 |
News Archive
Millions of individuals all over the country suffer from obesity, preventing them from living an active lifestyle, as well as causing a number of health conditions, such as heart disease, diabetes, and high blood pressure.
Five health prevention strategies could save more than 100,000 lives a year, according to recent research reported in the March issue of Mayo Clinic Women's HealthSource.
Researchers used ultrasound to measure the thickness of the inner walls of the neck (carotid) arteries that supply blood to the brain. Increasing carotid artery intima-media thickness (CIMT) indicates the fatty buildup of plaque within arteries feeding the heart muscle and the brain, which can lead to heart attack or stroke.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tuan Tran, MD Po Box 144333, Orlando, FL 32814-4333 Ph: (407) 422-9831 | Tuan Tran, MD 1 Memorial Dr, Alton, IL 62002-6722 Ph: (314) 653-5630 |
News Archive
Millions of individuals all over the country suffer from obesity, preventing them from living an active lifestyle, as well as causing a number of health conditions, such as heart disease, diabetes, and high blood pressure.
Five health prevention strategies could save more than 100,000 lives a year, according to recent research reported in the March issue of Mayo Clinic Women's HealthSource.
Researchers used ultrasound to measure the thickness of the inner walls of the neck (carotid) arteries that supply blood to the brain. Increasing carotid artery intima-media thickness (CIMT) indicates the fatty buildup of plaque within arteries feeding the heart muscle and the brain, which can lead to heart attack or stroke.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
› Verified 7 days ago
Isidro S Tolod, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Saint Anthonys Way, Alton, IL 62002 Phone: 618-465-4511 Fax: 618-474-6018 | |
Jeffrey H Kiviat, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7410 Fax: 618-463-7641 | |
Dr. Sarah E Starnes, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Saint Anthonys Way, Alton, IL 62002 Phone: 618-465-2571 Fax: 314-977-7615 |